MGO One Seven LLC Purchases 20,813 Shares of Danaher Corporation (NYSE:DHR)

Key Points

• MGO One Seven LLC increased its stake in Danaher Corporation by 485.7%, purchasing an additional 20,813 shares, bringing its total to 25,098 shares valued at approximately $5.15 million.
• Danaher reported a Q2 earnings per share of $1.80, surpassing analyst estimates of $1.64 and showing a 3.4% year-over-year revenue growth to $5.94 billion.
• The company declared a quarterly dividend of $0.32 per share, resulting in an annualized dividend of $1.28 and a yield of 0.63%.

MGO One Seven LLC lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 485.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 25,098 shares of the conglomerate's stock after purchasing an additional 20,813 shares during the quarter. MGO One Seven LLC's holdings in Danaher were worth $5,145,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of DHR. GHP Investment Advisors Inc. boosted its stake in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate's stock valued at $25,000 after buying an additional 99 shares in the last quarter. Heck Capital Advisors LLC bought a new position in Danaher during the fourth quarter valued at about $27,000. Sierra Ocean LLC boosted its stake in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate's stock valued at $29,000 after buying an additional 76 shares in the last quarter. Smallwood Wealth Investment Management LLC bought a new position in Danaher during the first quarter valued at about $31,000. Finally, Hurley Capital LLC bought a new position in Danaher during the fourth quarter valued at about $34,000. Institutional investors own 79.05% of the company's stock.

Analyst Ratings Changes

DHR has been the subject of several research reports. The Goldman Sachs Group decreased their target price on Danaher from $260.00 to $240.00 and set a "neutral" rating for the company in a research note on Wednesday, April 23rd. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $250.00 target price on shares of Danaher in a research note on Wednesday, April 23rd. Leerink Partners upped their target price on Danaher from $225.00 to $230.00 and gave the company an "outperform" rating in a report on Wednesday, April 23rd. Evercore ISI reduced their target price on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Finally, Robert W. Baird upped their target price on Danaher from $225.00 to $226.00 and gave the company an "outperform" rating in a report on Friday, July 18th. Three research analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Insider Buying and Selling at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman owned 3,105,808 shares in the company, valued at $611,036,665.92. This trade represents a 28.70% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 11.10% of the company's stock.

Danaher Stock Performance

Shares of NYSE:DHR traded down $0.08 during trading on Friday, hitting $197.08. 5,736,543 shares of the stock were exchanged, compared to its average volume of 4,375,955. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The company has a market capitalization of $141.12 billion, a price-to-earnings ratio of 41.93, a price-to-earnings-growth ratio of 2.74 and a beta of 0.73. The company's fifty day simple moving average is $197.49 and its 200-day simple moving average is $202.68. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%. The company had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same quarter last year, the firm earned $1.72 EPS. Danaher's revenue for the quarter was up 3.4% compared to the same quarter last year. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 25th. Stockholders of record on Friday, June 27th were issued a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher's payout ratio is presently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.